Microsoft, Apollo Hospitals join hands for cardiac disease detection
News

Microsoft, Apollo Hospitals join hands for cardiac disease detection

Views: 1.7K

The tech-giant Microsoft has joined hands with Apollo healthcare to create an AI-focused network in cardiology. The AI Network for healthcare, previously known as Microsoft Intelligent Network for eyecare (MINE) is a part of Microsoft Healthcare NExT, aimed to accelerate healthcare innovations through artificial intelligence and cloud computing.

Both of these world’s leading organisations will work to develop and deploy new machine learning models to predict patient risk for heart disease and assists doctors on treatment plans.

Talking about the development, Dr Peter Lee, Corporate Vice President, AI & Research, Microsoft said, “AI Network for healthcare aims to democratise artificial intelligence by empowering healthcare providers with faster, intuitive and predictable solutions and reducing the disease burden.”

“Our unique partnership with Apollo brings together our learnings in artificial intelligence and machine learning areas and Apollo’s experience and expertise in cardiology.  The systems of intelligence we create can change the lives of patients and the work of medical practitioners enabling accessible healthcare to all,” Lee further stated.

Sangita Reddy, Joint Managing Director, Apollo Hospitals said this collaboration marks a paradigm shift for patients and the management of non-communicable diseases across the world.

“Cardiac disease is amongst India’s leading causes of mortality and morbidity, which is exacting a toll on the health and well-being of our citizens. Given our large clinical database and significant pool of clinical talent, this partnership will help impact the global burden of cardiac disease,”Reddy said.

“This collaboration with Microsoft’s path-breaking technologies like Artificial Intelligence and Machine Learning will help better predict, prevent and manage heart disease in the country. While we commence this in India, we will validate the algorithms and work towards creating a global consortium to tackle multiple conditions in cardiovascular disease,” she further said.

Recommended from all portals

Latest News

To Top